595 related articles for article (PubMed ID: 28396624)
1. Granulostasis: Protein Quality Control of RNP Granules.
Alberti S; Mateju D; Mediani L; Carra S
Front Mol Neurosci; 2017; 10():84. PubMed ID: 28396624
[TBL] [Abstract][Full Text] [Related]
2. BAG3 and BAG6 differentially affect the dynamics of stress granules by targeting distinct subsets of defective polypeptides released from ribosomes.
Mediani L; Galli V; Carrà AD; Bigi I; Vinet J; Ganassi M; Antoniani F; Tiago T; Cimino M; Mateju D; Cereda C; Pansarasa O; Alberti S; Mandrioli J; Carra S
Cell Stress Chaperones; 2020 Nov; 25(6):1045-1058. PubMed ID: 32696179
[TBL] [Abstract][Full Text] [Related]
3. An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function.
Mateju D; Franzmann TM; Patel A; Kopach A; Boczek EE; Maharana S; Lee HO; Carra S; Hyman AA; Alberti S
EMBO J; 2017 Jun; 36(12):1669-1687. PubMed ID: 28377462
[TBL] [Abstract][Full Text] [Related]
4. A Surveillance Function of the HSPB8-BAG3-HSP70 Chaperone Complex Ensures Stress Granule Integrity and Dynamism.
Ganassi M; Mateju D; Bigi I; Mediani L; Poser I; Lee HO; Seguin SJ; Morelli FF; Vinet J; Leo G; Pansarasa O; Cereda C; Poletti A; Alberti S; Carra S
Mol Cell; 2016 Sep; 63(5):796-810. PubMed ID: 27570075
[TBL] [Abstract][Full Text] [Related]
5. Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders.
Naskar A; Nayak A; Salaikumaran MR; Vishal SS; Gopal PP
Front Mol Neurosci; 2023; 16():1242925. PubMed ID: 37720552
[TBL] [Abstract][Full Text] [Related]
6. Loss of PML nuclear bodies in familial amyotrophic lateral sclerosis-frontotemporal dementia.
Antoniani F; Cimino M; Mediani L; Vinet J; Verde EM; Secco V; Yamoah A; Tripathi P; Aronica E; Cicardi ME; Trotti D; Sterneckert J; Goswami A; Carra S
Cell Death Discov; 2023 Jul; 9(1):248. PubMed ID: 37454169
[TBL] [Abstract][Full Text] [Related]
7. Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
Mandrioli J; Crippa V; Cereda C; Bonetto V; Zucchi E; Gessani A; Ceroni M; Chio A; D'Amico R; Monsurrò MR; Riva N; Sabatelli M; Silani V; Simone IL; Sorarù G; Provenzani A; D'Agostino VG; Carra S; Poletti A
BMJ Open; 2019 May; 9(5):e028486. PubMed ID: 31152038
[TBL] [Abstract][Full Text] [Related]
8. Molecular interaction of stress granules with Tau and autophagy in Alzheimer's disease.
Yu QY; Ye LQ; Li HL
Neurochem Int; 2022 Jul; 157():105342. PubMed ID: 35461975
[TBL] [Abstract][Full Text] [Related]
9. Role of Proteostasis Regulation in the Turnover of Stress Granules.
Hu R; Qian B; Li A; Fang Y
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498892
[TBL] [Abstract][Full Text] [Related]
10. Friend or foe-Post-translational modifications as regulators of phase separation and RNP granule dynamics.
Hofweber M; Dormann D
J Biol Chem; 2019 May; 294(18):7137-7150. PubMed ID: 30587571
[TBL] [Abstract][Full Text] [Related]
11. Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules.
Markmiller S; Soltanieh S; Server KL; Mak R; Jin W; Fang MY; Luo EC; Krach F; Yang D; Sen A; Fulzele A; Wozniak JM; Gonzalez DJ; Kankel MW; Gao FB; Bennett EJ; Lécuyer E; Yeo GW
Cell; 2018 Jan; 172(3):590-604.e13. PubMed ID: 29373831
[TBL] [Abstract][Full Text] [Related]
12. Stress granule-mediated RNA regulatory mechanism in Alzheimer's disease.
Sato K; Takayama KI; Inoue S
Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():7-14. PubMed ID: 37726158
[TBL] [Abstract][Full Text] [Related]
13. RNP granules in ALS and neurodegeneration: From multifunctional membraneless organelles to therapeutic opportunities.
Shelkovnikova TA; Hautbergue GM
Int Rev Neurobiol; 2024; 176():455-479. PubMed ID: 38802180
[TBL] [Abstract][Full Text] [Related]
14. ALS and FTD: Where RNA metabolism meets protein quality control.
Mandrioli J; Mediani L; Alberti S; Carra S
Semin Cell Dev Biol; 2020 Mar; 99():183-192. PubMed ID: 31254610
[TBL] [Abstract][Full Text] [Related]
15. Relation Between Stress Granules and Cytoplasmic Protein Aggregates Linked to Neurodegenerative Diseases.
Dobra I; Pankivskyi S; Samsonova A; Pastre D; Hamon L
Curr Neurol Neurosci Rep; 2018 Nov; 18(12):107. PubMed ID: 30406848
[TBL] [Abstract][Full Text] [Related]
16. The Integral Role of RNA in Stress Granule Formation and Function.
Campos-Melo D; Hawley ZCE; Droppelmann CA; Strong MJ
Front Cell Dev Biol; 2021; 9():621779. PubMed ID: 34095105
[TBL] [Abstract][Full Text] [Related]
17. Stress Granule Homeostasis, Aberrant Phase Transition, and Amyotrophic Lateral Sclerosis.
Li Z; Liu X; Liu M
ACS Chem Neurosci; 2022 Aug; 13(16):2356-2370. PubMed ID: 35905138
[TBL] [Abstract][Full Text] [Related]
18. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.
Bentmann E; Haass C; Dormann D
FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065
[TBL] [Abstract][Full Text] [Related]
19. Changing faces of stress: Impact of heat and arsenite treatment on the composition of stress granules.
Frydrýšková K; Mašek T; Pospíšek M
Wiley Interdiscip Rev RNA; 2020 Nov; 11(6):e1596. PubMed ID: 32362075
[TBL] [Abstract][Full Text] [Related]
20. Dr. Jekyll and Mr. Hyde? Physiology and Pathology of Neuronal Stress Granules.
Jeon P; Lee JA
Front Cell Dev Biol; 2021; 9():609698. PubMed ID: 33718353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
